Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Cboe UK • GBp AstraZeneca PLC (AZNL.XC) Follow Compare 11,908.00 -90.00 (-0.75%) At close: 4:29:49 PM GMT Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Vertex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for AZNL.XC 1D 5D 0.37% 1M 1.57% 3M 13.54% 6M -0.62% YTD 13.91% 1Y 15.63% 5Y 76.89% All 344.33% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: AZNL.XC View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations European Equities Rise in Monday Trading; AstraZeneca to Acquire EsoBiotec for Up to $1 Billion AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals Eventful Monday For AstraZeneca - What's Going On? Trending tickers: Nvidia, Berkshire Hathaway, Baidu, QinetiQ and AstraZeneca AstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotec AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition